会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Generating device, generating method, program and recording medium
    • 生成装置,生成方法,程序和记录介质
    • US07979765B2
    • 2011-07-12
    • US12442996
    • 2007-09-25
    • Xiaoqing WenSeiji KajiharaKohei MiyaseYoshihiro MinamotoHiroshi Date
    • Xiaoqing WenSeiji KajiharaKohei MiyaseYoshihiro MinamotoHiroshi Date
    • G01R31/28G06F11/00
    • G11C29/10G01R31/31721G01R31/31813G01R31/31917G11C29/56004
    • Provided are a generation device and the like for generating a test vector which can reduce capture power efficiently. The generation device 100 generates a test vector for a logic circuit by assigning logic values to each of a plurality of unspecified bits (X-bits) included in a test cube. The generation device 100 includes a selection unit 101 for selecting, among the plurality of X-bits, a target X-bit, which is a target of assigning a logic value, a capture transition metric calculation unit 103 for calculating capture transition metric caused by a test cube including an X-bit, and a logic value assignment unit 105 for assigning, to the selected target X-bit, a logic value which causes the smaller capture transition metric, by applying the capture transition metric calculation means to a first test cube obtained by assigning a logic value 0 to the selected target X-bit and to a second test cube obtained by assigning a logic value 1 to the selected target X-bit, and by comparing a capture transition metric caused by a first test cube and a capture transition metric caused by a second test cube.
    • 提供了用于生成能够有效地降低捕获功率的测试向量的生成装置等。 生成装置100通过向包括在测试立方体中的多个未指定位(X位)中的每一个分配逻辑值来生成用于逻辑电路的测试向量。 生成装置100包括:选择单元101,用于在多个X位中选择作为分配逻辑值的目标的目标X位;捕获转移度量计算单元103,用于计算由 包括X位的测试立方体和用于通过将捕获转移度量计算装置应用于第一测试来向所选择的目标X位分配导致较小捕获转换度量的逻辑值的逻辑值分配单元105 通过将逻辑值0分配给所选择的目标X位获得的立方体以及通过将逻辑值1分配给所选择的目标X位获得的第二测试立方体,并且通过将由第一测试立方体引起的捕获转变度量与 由第二个测试立方体引起的捕获转换度量。
    • 2. 发明授权
    • Generating device, generating method, program and recording medium
    • 生成装置,生成方法,程序和记录介质
    • US07962822B2
    • 2011-06-14
    • US12235628
    • 2008-09-23
    • Xiaoqing WenSeiji KajiharaKohei MiyaseYoshihiro MinamotoHiroshi Date
    • Xiaoqing WenSeiji KajiharaKohei MiyaseYoshihiro MinamotoHiroshi Date
    • G01R31/28
    • G01R31/318544G01R31/318502
    • A generation apparatus and the like for generating a test vector set capable of reducing differences in a logic value generated before and after a scan capture for outputs from scan cells included in a full-scan sequential circuit are provided. A generation apparatus 200 generating an initial test vector set 216 for a logic circuit includes a target vector identification unit 204 identifying a test vector satisfying a predetermined criterion and to be selected for the number of bits (the number of bit transitions) whose logic values differ before and after scan capture with respect to outputs from scan cells included in the sequential circuit, from among test vectors in the initial test vector set 216, and a test vector set conversion unit 206 converting the test vector identified by the test vector identification unit 204 and to be selected so as to reduce the number of bit transitions with respect to outputs from the scan cells included in the sequential circuit.
    • 提供了一种用于生成能够减少在扫描捕获之前和之后产生的逻辑值中的差异的测试向量集的生成装置等,用于从全扫描时序电路中包括的扫描单元的输出。 生成用于逻辑电路的初始测试向量集合216的生成装置200包括:目标矢量识别单元204,其识别满足预定标准的测试向量,并且对于其逻辑值不同的位数(位数转换的数量)来选择 相对于包括在顺序电路中的扫描单元的输出,从初始测试向量集合216的测试向量中的扫描捕获之前和之后,以及转换由测试向量识别单元204识别的测试向量的测试向量集合转换单元206 并且被选择为减少相对于包括在顺序电路中的扫描单元的输出的位转换的数量。
    • 3. 发明申请
    • Novel Use of Ansamycin Antibiotics And Method of Screening Novel Angiogenesis Inhibitor
    • 新霉素抗生素的使用和筛选新型血管生成抑制剂的方法
    • US20100004327A1
    • 2010-01-07
    • US12504823
    • 2009-07-17
    • Masayoshi ShichiriYujiro Tanaka
    • Masayoshi ShichiriYujiro Tanaka
    • A61K31/395
    • A61K31/395A61K31/496G01N33/5011
    • The present invention provides novel angiogenesis inhibitors effective, safe and highly practical for inhibition of angiogenesis in various diseases, and a method for screening the same. The active ingredients of the angiogenesis inhibitors of the present invention comprise ansamycin antibiotics such as rifampicin, rifamycin SV and 3-formyl rifamycin, which have long been used extensively as antibacterial agents for treating tuberculosis or Gram-positive bacterial infections. The active ingredients of the present invention have excellent angiogenesis-inhibiting activity. The angiogenesis inhibitor of the present invention is effective for inhibition of angiogenesis in malignant tumors, diabetic retinopathy, retinal angiogenesis, inflammatory diseases, and angiogenesis accompanying cardiovascular remodeling, etc., and can be used as therapeutic agents against each disease, etc. Further, the screening method of the present invention makes it possible to perform an effective screening of angiogenesis-inhibiting substances by detecting angiogenesis-inhibiting signals based on gene expression levels.
    • 本发明提供了用于抑制各种疾病中的血管发生的有效,安全和高度实用的新型血管生成抑制剂及其筛选方法。 本发明的血管发生抑制剂的活性成分包括长时久以来被广泛用作治疗结核病或革兰氏阳性细菌感染的抗菌剂的安莎霉素抗生素如利福平,利福霉素SV和3-甲酰基利福霉素。 本发明的活性成分具有优异的血管生成抑制活性。 本发明的血管生成抑制剂对于抑制恶性肿瘤,糖尿病性视网膜病变,视网膜血管生成,炎症性疾病以及伴随心血管重塑等的血管发生等,对于抑制血管生成有效,可用作针对各种疾病的治疗剂等。另外, 通过本发明的筛选方法,可以通过基于基因表达水平检测血管生成抑制信号来进行血管新生抑制物质的有效筛选。
    • 4. 发明授权
    • Method of examining colon cancer and colon adenoma
    • 检查结肠癌和结肠腺瘤的方法
    • US07601348B2
    • 2009-10-13
    • US10568544
    • 2004-07-09
    • Reiji KannagiMineko IzawaTakashi MuramatsuKenji UchimuraHideaki Hosokawa
    • Reiji KannagiMineko IzawaTakashi MuramatsuKenji UchimuraHideaki Hosokawa
    • A61K39/395
    • G01N33/57419G01N2333/91097G01N2400/02
    • The present invention provides a method for examining colorectal cancer and colorectal adenoma, which enables to detect colorectal cancer patients and patients at high risk of colorectal cancer at a high probability and is useful for diagnosis of colorectal cancer and colorectal adenoma, and provides the examination reagents thereof. The present inventors discovered that there are significant differences in the distribution of GlcNAc-6-sulfotransferase isozymes, sulfation enzymes of sugar residues, among non-cancer colorectal tissues, colorectal cancer tissues and colorectal adenoma tissues. Furthermore the inventors applied the discovery to diagnosis and found that colorectal cancers and adenomas are detected specifically by assaying a definite range of GlcNAc-6-sulfated sugar residues in tissues from patients or feces samples. MECA-79 antibody (Pharmingen, catalog No. 09961D, Distributor: Becton Dickinson), reacting with GlcNAc-6-sulfated sugar residues, which are produced specifically by the enzyme present in colorectal cancer and colorectal adenoma tissues could be used for the examination of colorectal cancers and colorectal adenomas.
    • 本发明提供一种检查结肠直肠癌和结肠直肠腺瘤的方法,其能够以高概率检测结肠直肠癌患者和结肠直肠癌风险高的患者,并且可用于诊断结肠直肠癌和结肠直肠腺瘤,并提供检查试剂 其中。 本发明人发现,GlcNAc-6-磺基转移酶同工酶,糖残基的硫酸化酶在非癌结肠直肠组织,结肠直肠癌组织和结肠直肠腺瘤组织中的分布存在显着差异。 此外,本发明人将该发现应用于诊断,并发现通过测定来自患者或粪便样品的组织中GlcNAc-6-硫酸化糖残基的确定范围来特异性检测结肠直肠癌和腺瘤。 与存在于结肠直肠癌和结肠直肠腺瘤组织中的酶特异性产生的GlcNAc-6硫酸化糖残基反应的MECA-79抗体(Pharmingen,目录号09961D,经销商:Becton Dickinson)可用于检查 结肠直肠癌和结直肠腺瘤。
    • 5. 发明授权
    • Method of analyzing physiological function of target substance
    • 分析目标物质生理功能的方法
    • US07553624B2
    • 2009-06-30
    • US10557906
    • 2004-05-20
    • Takeharu NagaiAtsushi Miyawaki
    • Takeharu NagaiAtsushi Miyawaki
    • C12Q1/68C12Q1/70G01N33/53C07H19/04C07H21/02
    • G01N33/533
    • The present invention provides a method of analyzing the physiological function of a target substance by inactivating the physiological function of the target substance, comprising the steps of: (a) binding to the target substance a photoactive compound represented by formula (I): (in the formula, Q is a group for binding this compound with the target substance) to form a composite comprising the target substance and the photoactive compound; and (b) irradiating the obtained composite with light to inactivate the function of the target substance to which the photoactive compound has been bound, or to inactivate the function of the target substance at the site where the photoactive compound has been bound.
    • 本发明提供了通过使目标物质的生理功能失活来分析目标物质的生理功能的方法,包括以下步骤:(a)与目标物质结合由式(I)表示的光活性化合物:(在 式中,Q为与化合物与目标物质结合的基团),形成包含目标物质和光活性化合物的复合体; 和(b)用光照射得到的复合物,使光活性化合物结合的目标物质的功能失活,或者使光活性化合物结合的位置失活目标物质的功能。
    • 9. 发明授权
    • Conversion device, conversion method, program, and recording medium
    • 转换装置,转换方法,程序和记录介质
    • US08037387B2
    • 2011-10-11
    • US12345310
    • 2008-12-29
    • Seiji KajiharaKohei MiyaseXiaqing WenYoshihiro MinamotoHiroshi Date
    • Seiji KajiharaKohei MiyaseXiaqing WenYoshihiro MinamotoHiroshi Date
    • G06F11/00
    • G01R31/318328G01R31/318335
    • Provided are a conversion device and the like for converting a initial test pattern given in advance into a test pattern of a bit constitution of different logic values, without losing the fault coverage of transition delay fault which can be detected by the constitution element of the initial test pattern. The conversion device converts an initial test pattern 100a given in advance for a logic circuit into an intermediate test pattern 100b of a bit constitution of different logic values, where the constitution elements of the initial test pattern 100a are at least two test vectors applied in succession. The conversion device includes a decision means for deciding a combination of logic values in the initial test pattern 100a which meet a detection condition of faults of the logic circuit which can be detected by applying the constitution elements.
    • 提供了一种用于将预先给出的初始测试图案转换成不同逻辑值的比特构造的测试图案的转换装置等,而不会丢失可由初始化的构成元素检测到的过渡延迟故障的故障覆盖 测试模式。 转换装置将用于逻辑电路的预先给出的初始测试图案100a转换成不同逻辑值的比特结构的中间测试图案100b,其中初始测试图案100a的构成元素是连续应用的至少两个测试矢量 。 转换装置包括判定装置,用于决定初始测试图案100a中的逻辑值的组合,其满足通过应用构成要素可以检测的逻辑电路的故障的检测条件。
    • 10. 发明授权
    • Conversion device, conversion method, program, and recording medium
    • 转换装置,转换方法,程序和记录介质
    • US07971118B2
    • 2011-06-28
    • US12129746
    • 2008-05-30
    • Xiaoqing WenSeiji KajiharaKohei MiyaseYoshihiro MinamotoHiroshi Date
    • Xiaoqing WenSeiji KajiharaKohei MiyaseYoshihiro MinamotoHiroshi Date
    • G01R31/28G06F11/00
    • G01R31/318547G01R31/318335G01R31/318502
    • Provided are a conversion device and others for converting a test vector set so as to reduce a logic value difference generated before and after scan capture in outputs of scan cells included in a full scan sequential circuit. A conversion device converts a test vector set corresponding to the full scan sequential circuit. The conversion device comprises a setting unit for setting a candidate bit which can be a don't care bit and a fixed bit which cannot be the don't care bit according to predetermined constraint conditions based on an input-output relationship in the logic circuit in order to identify the don't care bit identifiable as don't care from each test vector of the test vector set, and a logic value deciding unit for deciding a logic value for the don't care bit in view of a relationship in a plurality of bit pairs in relation to a test cube including the don't care bit identified by the setting unit.
    • 提供了一种转换装置和其他用于转换测试矢量集,以便减少在全扫描时序电路中包括的扫描单元的输出中扫描捕获之前和之后产生的逻辑值差。 转换装置转换对应于全扫描时序电路的测试矢量集。 转换装置包括:设置单元,用于根据预定的约束条件,基于逻辑电路中的输入 - 输出关系设置可以是无关位的候选比特和不能不关心比特的固定比特 为了识别不关心的位,可以从测试向量集合的每个测试向量不关心,以及逻辑值决定单元,用于根据关系中的关系来确定无关位的逻辑值 相对于包括由设置单元标识的无关位的测试立方体的多个位对。